Primary hypothyroidism and quality of life
Top Cited Papers
- 18 January 2022
- journal article
- review article
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 18 (4) , 230-242
Abstract
In the 1970s, treatment with thyroid extract was superseded by levothyroxine, a synthetic l form of tetraiodothyronine. Since then, no major innovation has emerged for the treatment of hypothyroidism. The biochemical definition of subclinical hypothyroidism is a matter of debate. Indiscriminate screening for hypothyroidism has led to overdiagnosis and treatment initiation at lower serum levels of thyroid-stimulating hormone (TSH) than previously. Adverse health effects have been documented in individuals with hypothyroidism or hyperthyroidism, and these adverse effects can affect health-related quality of life (QOL). Levothyroxine substitution improves, but does not always normalize, QOL, especially for individuals with mild hypothyroidism. However, neither studies combining levothyroxine and liothyronine (the synthetic form of tri-iodothyronine) nor the use of desiccated thyroid extract have shown robust improvements in patient satisfaction. Future studies should focus not only on a better understanding of an individual’s TSH set point (the innate narrow physiological range of serum concentration of TSH in an individual, before the onset of hypothyroidism) and alternative thyroid hormone combinations and formulations, but also on autoimmunity and comorbidities unrelated to hypothyroidism as drivers of patient dissatisfaction. Attention to the long-term health consequences of hypothyroidism, beyond QOL, and the risks of overtreatment is imperative.Keywords
This publication has 142 references indexed in Scilit:
- Thyroid Hormone Status and Health-Related Quality of Life in the LifeLines Cohort StudyThyroid®, 2013
- The Natural History of Subclinical Hypothyroidism in the Elderly: The Cardiovascular Health StudyThe Journal of Clinical Endocrinology & Metabolism, 2012
- Systematic review of health-related quality of life modelsHealth and Quality of Life Outcomes, 2012
- Changes of subtests of Wechsler Memory Scale and cognitive function in subjects with subclinical hypothyroidism following treatment with levothyroxineArchives of Medical Science, 2012
- Paracrine signaling by glial cell–derived triiodothyronine activates neuronal gene expression in the rodent brain and human cellsJournal of Clinical Investigation, 2010
- Self-efficacy instruments for patients with chronic diseases suffer from methodological limitations - a systematic reviewHealth and Quality of Life Outcomes, 2009
- Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled studyClinical Endocrinology, 2009
- Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1Endocrine Reviews, 2008
- Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidismEuropean Journal of Endocrinology, 2005
- Thyroid-Pituitary InteractionNew England Journal of Medicine, 1982